Perrigo | PRGO - Pre Tax Profit


Perrigo reported $22.4M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 2.67B 1.71B Dec/2025
Abbott USD 2.39B 27M Mar/2026
Bayer EUR -1.16B 735M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Dr.Reddys Laboratories INR 15.68B 2.38B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
J&J USD 7.82B 2.86B Mar/2026
Merck USD 6.74B 22M Sep/2025
Nestle CHF 7.24B 1.1B Jun/2024
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 69.13M 7.35M Sep/2025
Reckitt Benckiser GBP 1.54B 73M Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zoetis USD 887M 15M Sep/2025